Uncategorized BREAKING NEWS: BioPharmAnalyses and Octopusyx BioConsulting are happy to announce the release of the second issue of their “BRIEFING ON CART-T CELLS TRIALS” Posted on 18/01/202018/01/2020 by Olivier For futher informations, see (http://biopharmanalyses.fr/product/briefing-on-cart-t-cells-trials-2020/) Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences Number of UK clinical trials of cell and gene therapies explodes